Related Experiment Video
Updated: Jul 11, 2026
06:45
Use of Electron Paramagnetic Resonance in Biological Samples at Ambient Temperature and 77 K
Published on: January 11, 2019
Pediatric environmental medicine in Eastern Central Europe
S Muceniece1, M Muszynska, M Otto
1State Agency Public Health Agency, Riga, Latvia.
International Journal of Hygiene and Environmental Health
|September 18, 2007
Summary
Pediatric environmental medicine requires development across Central and Eastern Europe. Support is needed at all levels to advance this crucial field for child health.
Area of Science:
- Environmental Medicine
- Pediatric Health
- Public Health Policy
Background:
- Pediatric environmental medicine is underdeveloped in Central and Eastern Europe.
- The challenges faced are similar to those in Central Europe, though perhaps more pronounced quantitatively.
Purpose of the Study:
- To highlight the need for support and development in pediatric environmental medicine in Central and Eastern Europe.
- To underscore the current state and future requirements for the field.
Main Methods:
- Qualitative assessment of the current status of pediatric environmental medicine.
- Comparative analysis with Central European regions.
Main Results:
- Pediatric environmental medicine in Central and Eastern Europe is in need of significant support.
- The field requires development on national, institutional, and individual levels.
Conclusions:
- Urgent action is required to bolster pediatric environmental medicine in the region.
- Strategic investment and policy changes are essential for progress.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...